Follicular lymphoma is listed as a "rare disease" by the Office of Rare Diseases (ORD) of the National Institutes of Health (NIH). This means that Follicular lymphoma, or a subtype of Follicular lymphoma, affects less than 200,000 people in the US population.
Ophanet, who are a consortium of European partners, currently defines a condition rare when if affects 1 person per 2,000. They list Follicular lymphoma as a "rare disease". More information about Follicular lymphoma is available from Orphanet
16 MEDICAL BOOKS ONLINE! Review excerpts from medical books online, free, without registration, for more information about the prevalence and/or incidence of Follicular lymphoma.
The cause of non-Hodgkin's lymphoma is unknown, although some theories suggest a viral source. Since the early 1970s, the incidence of these lymphomas has increased more than 80%, with about 53,000 new cases appearing annually in the United States. The reason for the increase is unknown, although it has been partly attributed to acquired immunodeficiency syndrome. Non-Hodgkin's lymphomas are two to three times more common in males than in females and occur in all age-groups. Compared to Hodgkin's disease, they occur about one to three times more often and cause twice as many deaths in children younger than age 15. Incidence rises with age (median age is 50). These lymphomas seem linked to certain races and ethnic groups, with increased incidence in whites and people of Jewish ancestry.
Source: Professional Guide to Diseases (Eighth Edition), 2005
The term 'prevalence' of Follicular lymphoma usually refers to the estimated population of people who are managing Follicular lymphoma at any given time. The term 'incidence' of Follicular lymphoma refers to the annual diagnosis rate, or the number of new cases of Follicular lymphoma diagnosed each year. Hence, these two statistics types can differ: a short-lived disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics.
What do you think about the features of this website? Take our user survey and have your say:
Next articles:
Tools & Services:
Medical Articles:
Search Specialists by State and City
By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.
Copyright © 2009 Health Grades Inc. All rights reserved.
Learn about new treatments available for patients with relapsed, indolent non-Hodgkin's lymphoma, as well as potential future treatments.
Every year, the Lymphoma Research Foundation hosts a forum for people living with lymphoma and the healthcare professionals that care for them....
Almost a quarter of all non-Hodgkin's lymphoma is classfied as follicular lymphoma. However, there are various options for treatment and choosing the...